Cary Street Partners Investment Advisory’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-908
Closed -$63K 1133
2023
Q3
$63K Hold
908
﹤0.01% 803
2023
Q2
$73.5K Buy
908
+15
+2% +$1.23K ﹤0.01% 726
2023
Q1
$72.1K Buy
893
+20
+2% +$1.61K 0.01% 666
2022
Q4
$65.3K Buy
+873
New +$62.2K ﹤0.01% 676

Other funds holding HOLX

Cary Street Partners Investment Advisory's HOLX Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Hologic (HOLX) in Q4 2023, closing a stake of 908 shares — an estimated $63K sold.

Cary Street Partners Investment Advisory first reported a position in HOLX in Q4 2022 and held it in 4 quarters. The position peaked at $73.5K in Q2 2023. 733 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 908 Hologic shares in Q4 2023, an estimated $63K.
  • Cary Street Partners Investment Advisory first reported a position in Hologic in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Hologic position peaked at $73.5K in Q2 2023.
  • 733 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.